Mark S. Blumenkranz Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark S. Blumenkranz.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark S. Blumenkranz. Mark S. Blumenkranz is a Director in 1Life Healthcare Inc ($ONEM) and a Director in IVERIC bio, Inc. ($OPHT) and a Director in Adverum Biotechnologies, Inc. ($AAVL) and a Director in Presbia PLC ($LENS).
Address: C/O AVALANCHE BIOTECHNOLOGIES, INC. 1035 O'BRIEN DRIVE, SUITE A MENLO PARK 94025 CA
Companies in which Mark S. Blumenkranz is an Insider
1Life Healthcare Inc
Industry: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
Position of Mark S. Blumenkranz: Director
Holdings: 0 shares
Latest Transaction: May 18 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Adverum Biotechnologies, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Mark S. Blumenkranz: Director
Holdings: 531,322 shares
Latest Transaction: Feb 17 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IVERIC bio, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark S. Blumenkranz: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 20 2021
$OPHT Market Capitalization: $156.71M
$OPHT Previous Close: $4.43
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Presbia PLC
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Mark S. Blumenkranz: Director
Holdings: 9,270 shares
Current Value: $30,591
Latest Transaction: Mar 18 2015
$LENS Market Capitalization: $43.35M
$LENS Previous Close: $3.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Mark S. Blumenkranz
Sentiment: All, ONEM, ADVM, OPHT, LENS
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 20 2021 | OPHT | IVERIC bio, Inc. | Blumenkranz Mark S. | Director | Option Exercise | A | 0.00 | 7,500 | 0 | 7,500 | |
| May 20 2021 | OPHT | IVERIC bio, Inc. | Blumenkranz Mark S. | Director | Option Exercise | A | 6.82 | 15,500 | 105,710 | 15,500 | |
| Jul 17 2020 | OPHT | IVERIC bio, Inc. | Blumenkranz Mark S. | Director | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Jul 17 2020 | OPHT | IVERIC bio, Inc. | Blumenkranz Mark S. | Director | Option Exercise | A | 4.48 | 31,000 | 138,880 | 31,000 | |
| May 18 2020 | ONEM | 1Life Healthcare I ... | Blumenkranz Mark S. | Director | Option Exercise | A | 29.00 | 5,294 | 153,526 | 5,294 | |
| Feb 17 2016 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Option Exercise | A | 4.80 | 11,905 | 57,144 | 11,905 | |
| Feb 17 2016 | AAVL | Adverum Biotechnol ... | Blumenkranz Mark S. | Director | Grant | A | 0.00 | 8,333 | 0 | 531,322 | 523 K to 531.3 K (+1.59 %) |